We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Palatin Technologies Inc New | AMEX:PTN | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.01 | 0.54% | 1.87 | 1.95 | 1.81 | 1.86 | 135,566 | 21:15:03 |
CRANBURY, N.J., Aug. 6, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that it will be presenting at Canaccord Genuity's 39th Annual Growth Conference on Wednesday, August 7, 2019, at 10:30 am ET. The conference will be held at the InterContinental Hotel in Boston, MA.
Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs, including:
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases and conditions with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.Palatin.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/palatin-technologies-to-present-at-canaccord-genuitys-39th-annual-growth-conference-300896933.html
SOURCE Palatin Technologies, Inc.
Copyright 2019 PR Newswire
1 Year Palatin Technologies Chart |
1 Month Palatin Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions